1. Cover image - p. cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. List of contributors - p. v 6. Acknowledgements - p. vi 7. Preface - p. vii 8. List of abbreviations - p. viii 9. List of Tables - p. ix 10. List of Illustrations - p. x 11. 1. Recurrent thrush - p. x 12. 2. Herpes simplex virus - p. 4 13. 3. Lichen sclerosus - p. 8 14. 4. Lichen planus - p. 12 15. 5. Genital warts - p. 16 16. 6. The immunocompromised patient with genitourinary presentations - p. 20 17. 7. Intermenstrual/postcoital bleeding - p. 24 18. 8. Premenstrual syndrome - p. 27 19. 9. Postmenopausal bleeding - p. 36 20. 10. Domestic violence - p. 40 21. 11. Issues pertinent to migrant women—female genital mutilation - p. 44 22. 12. Toxic shock syndrome - p. 48 23. 13. Cervical screening in pregnancy - p. 52 24. 14. Chicken pox in pregnancy - p. 56 25. 15. Confidentiality - p. 62 26. 16. Contact tracing - p. 64 27. 17. Contraception for postpartum women - p. 70 28. 18. Contraception for women aged over 40 years and in the perimenopause - p. 79 29. 19. Polycystic ovary syndrome and contraception - p. 86 30. 20. Contraception for women with obesity - p. 97 31. 21. Contraception for women with eating disorders - p. 108 32. 22. Contraception for women with epilepsy - p. 116 33. 23. Emergency contraception - p. 126 34. 24. Contraception and sexual health in transgender individuals - p. 148 35. 25. Human immunodeficiency virus and contraception - p. 162 36. 26. Contraception and mental health - p. 176 37. Appendix A: The UK medical eligibility criteria for contraceptive use - p. 193 38. Appendix B: Contraception choices and effectiveness of contraceptive methods - p. 195 39. Index - p. 197
1. Cover image - p. cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. List of contributors - p. v 6. Acknowledgements - p. vi 7. Preface - p. vii 8. List of abbreviations - p. viii 9. List of Tables - p. ix 10. List of Illustrations - p. x 11. 1. Recurrent thrush - p. x 12. 2. Herpes simplex virus - p. 4 13. 3. Lichen sclerosus - p. 8 14. 4. Lichen planus - p. 12 15. 5. Genital warts - p. 16 16. 6. The immunocompromised patient with genitourinary presentations - p. 20 17. 7. Intermenstrual/postcoital bleeding - p. 24 18. 8. Premenstrual syndrome - p. 27 19. 9. Postmenopausal bleeding - p. 36 20. 10. Domestic violence - p. 40 21. 11. Issues pertinent to migrant women—female genital mutilation - p. 44 22. 12. Toxic shock syndrome - p. 48 23. 13. Cervical screening in pregnancy - p. 52 24. 14. Chicken pox in pregnancy - p. 56 25. 15. Confidentiality - p. 62 26. 16. Contact tracing - p. 64 27. 17. Contraception for postpartum women - p. 70 28. 18. Contraception for women aged over 40 years and in the perimenopause - p. 79 29. 19. Polycystic ovary syndrome and contraception - p. 86 30. 20. Contraception for women with obesity - p. 97 31. 21. Contraception for women with eating disorders - p. 108 32. 22. Contraception for women with epilepsy - p. 116 33. 23. Emergency contraception - p. 126 34. 24. Contraception and sexual health in transgender individuals - p. 148 35. 25. Human immunodeficiency virus and contraception - p. 162 36. 26. Contraception and mental health - p. 176 37. Appendix A: The UK medical eligibility criteria for contraceptive use - p. 193 38. Appendix B: Contraception choices and effectiveness of contraceptive methods - p. 195 39. Index - p. 197
